Aim­ing to up­root the mar­ket for asth­ma at­tacks, As­traZeneca and Avil­lion tout two PhI­II wins for in­haled com­bo drug

A col­lab­o­ra­tion launched in 2018 be­tween As­traZeneca and British com­pa­ny Avil­lion is bear­ing new fruit Thurs­day for a se­vere asth­ma pro­gram.

The As­traZeneca and Avil­lion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER